The PLLA resorbable scaffold supports the treated artery to address vessel recoil and dissection1, while the sustained everolimus elution inhibits restenosis and maximizes patency2. Ultimately the scaffold is completely resorbed*,2, leaving nothing behind.
After the scaffold has been implanted and delivers the drug into the vessel, it begins to resorb naturally and disappear into the body over time like dissolving stitches, with complete resorption.2
Representative photomicrographs of porcine coronary arteries implanted with Absorb BVS (1–48 months). Data on file at Abbott.
*Excluding platinum markers.
References
MAT-2408195 v1.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
